Nanjing Vazyme Biotech Co Ltd
SSE:688105
Nanjing Vazyme Biotech Co Ltd
Interest Income Expense
Nanjing Vazyme Biotech Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing Vazyme Biotech Co Ltd
SSE:688105
|
Interest Income Expense
¥71.4m
|
CAGR 3-Years
88%
|
CAGR 5-Years
225%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Interest Income Expense
-¥59.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Interest Income Expense
¥445.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Interest Income Expense
¥217.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Interest Income Expense
-¥33.6m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Interest Income Expense
¥100.8m
|
CAGR 3-Years
126%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing Vazyme Biotech Co Ltd's Interest Income Expense?
Interest Income Expense
71.4m
CNY
Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Interest Income Expense amounts to 71.4m CNY.
What is Nanjing Vazyme Biotech Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
225%
Over the last year, the Interest Income Expense growth was -21%. The average annual Interest Income Expense growth rates for Nanjing Vazyme Biotech Co Ltd have been 88% over the past three years , 225% over the past five years .